John P Richard Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John P Richard.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John P Richard. John P Richard is a Director in Aviragen Therapeutics, Inc. ($NABI) and a Director in CATALYST BIOSCIENCES, INC. ($CBIO) and a Director in Altus Pharmaceuticals Inc. ($ALTU).
Address: C/O ALTUS PHARMACEUTICALS INC. 125 SIDNEY STREET CAMBRIDGE 02139 MA
Companies in which John P Richard is an Insider
Altus Pharmaceuticals Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John P Richard: Director
Holdings: 0 shares
Latest Transaction: Jun 28 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CATALYST BIOSCIENCES, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John P Richard: Director
Holdings: 3,716 shares
Current Value: $2,192
Latest Transaction: Mar 13 2020
$CBIO Market Capitalization: $6.51M
$CBIO Previous Close: $0.59
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vaxart, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John P Richard: Director
Holdings: 20,000 shares
Current Value: $22,800
Latest Transaction: Oct 15 2019
$VXRT Market Capitalization: $43.28M
$VXRT Previous Close: $1.14
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of John P Richard
Sentiment: All, ALTU, CBIO, VXRT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13 2020 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Buy | P | 3.98 | 2,500 | 9,950 | 3,716 | 1.2 K to 3.7 K (+205.59 %) |
| Oct 15 2019 | AVIR | Vaxart, Inc. | Richard John P | Director | Buy | P | 0.38 | 20,000 | 7,680 | 20,000 | 0 to 20 K |
| Jun 17 2019 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | A | 7.46 | 5,000 | 37,300 | 5,000 | |
| Jun 14 2019 | AVIR | Vaxart, Inc. | Richard John P | Director | Option Exercise | A | 0.68 | 12,700 | 8,636 | 12,700 | |
| Jun 14 2019 | AVIR | Vaxart, Inc. | Richard John P | Director | Option Exercise | A | 0.68 | 9,000 | 6,120 | 9,000 | |
| May 28 2019 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Buy | P | 8.03 | 1,000 | 8,030 | 1,216 | 216 to 1.2 K (+462.96 %) |
| Jun 15 2018 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | A | 24.94 | 5,000 | 124,700 | 5,000 |